Anti-Human Serum

FDA 510(k) K791282 · Diagnostica, Inc.

Substantially Equivalent

510(k) numberK791282

Submission

Device name
Anti-Human Serum
Applicant
Diagnostica, Inc.
Mchenry, IL, US
Received
July 10, 1979
Decision date
October 17, 1979
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
DGQ – Whole Blood Plasma, Antigen, Antiserum, Control
Device class
Class I (low risk)
Regulation
21 CFR 866.5700
Specialty
Immunology

More from Diagnostica, Inc.

510(k)DeviceDecision
K002756Ease-A-CultKHE · Traditional 02/23/2001SE
K823348H. Influenza B Antisera for CieGRP · Traditional 12/28/1982SE
K812434Diagnostic Kits & Kit ComponentsLHT · Traditional 09/23/1981SE
K800398Paracontrol Abnormal Immunoglobulin ContDEW · Traditional 03/12/1980SE
K791284Anti-Human Kappa SerumDFH · Traditional 11/27/1979SE
K791283Anti-Human Lambda SerumDEH · Traditional 11/27/1979SE
K791281Anti-Human Igg SerumDEW · Traditional 11/27/1979SE
K791285Anti-Human GlobulinsDEW · Traditional 10/17/1979SE
K790672Aspergillus Fumigatus, Aspergillus FlavuJWT · Traditional 05/31/1979SE
K790671Dermatophytin OJXB · Traditional 05/31/1979SE

Questions and answers

When was Anti-Human Serum cleared by the FDA?

Anti-Human Serum (K791282) received a 510(k) decision of Substantially Equivalent on October 17, 1979, 99 days after the submission was received.

What is the product code of K791282?

The FDA product code is DGQ – Whole Blood Plasma, Antigen, Antiserum, Control, a Class I (low risk) device regulated under 21 CFR 866.5700.